SG
MDCX

StoneX Group’s Medicus Pharma MDCX Stock Holding History

StoneX Group’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.37K Buy
17,066
+1,897
+13% +$672 ﹤0.01% 1398
2026
Q1 		$6.96K Buy
+15,169
New +$15.8K ﹤0.01% 867

Other funds holding MDCX

ICP
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $479M AUM 31.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return

StoneX Group's MDCX Position: Q2 2026 in Review

StoneX Group increased its Medicus Pharma (MDCX) stake by 13% in Q2 2026, buying an estimated $672 and bringing the position to 17,066 shares worth $6.37K. The position accounts for ﹤0.01% of the portfolio, ranked #1398.

StoneX Group first reported a position in MDCX in Q1 2026 and has held it in 2 quarters since. The position peaked at $6.96K in Q1 2026. 23 funds tracked by Wall St. Rank hold MDCX as of Q2 2026.

  • StoneX Group held 17,066 shares of Medicus Pharma worth $6.37K as of Q2 2026.
  • StoneX Group bought 1,897 Medicus Pharma shares in Q2 2026, an estimated $672.
  • Medicus Pharma made up ﹤0.01% of StoneX Group's portfolio in Q2 2026, its #1398 holding.
  • StoneX Group first reported a position in Medicus Pharma in Q1 2026 and has held it in 2 quarters since.
  • StoneX Group's Medicus Pharma position peaked at $6.96K in Q1 2026.
  • 23 funds tracked by Wall St. Rank held Medicus Pharma as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.